To Determine the Safety, Tolerability, Pharmacokinetics and Effect on Pain of a Single Intra-articular Administration of Canakinumab in Patients With Osteoarthritis in the Knee
Clinical trial NCT01160822 · COMPLETED
Trial details
- NCT number
- NCT01160822
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-07-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.